Janet Huffman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-05-02–present
-
Oragenics Inc (OGEN)
SEC 8-K
Current2024-12-16–present
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Oragenics Inc (OGEN) | Chief Financial Officer, Chief Executive Officer | $285,801 | $609,157 |
| 2024 | Oragenics Inc (OGEN) | Chief Financial Officer, Interim Chief Executive Officer | $250,000 | $363,700 |
| 2023 | Oragenics Inc (OGEN) | Chief Financial Officer, Interim Chief Executive Officer | $208,333 | $420,346 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.